2008
191. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector.
Vogt S, Ueblacker P, Geis C, Wagner B, Wexel G, Tischer T, Krüger A, Plank C, Anton M, Martinek V, Imhoff AB, Gansbacher B
Biomaterials. 2008 Mar .
193. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies.
Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, Arlt M, Moldenhauer G, Fogel M, Krüger A, Altevogt P
Oncogene. 2008 Feb 21.
194. Monomolecular assembly of siRNA and poly(ethylene glycol)-peptide copolymers.
DeRouchey J, Schmidt C, Walker GF, Koch C, Plank C, Wagner E, Rädler JO
Biomacromolecules. 2008 Feb .
195. Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9F1.
Schrage A, Loddenkemper C, Erben U, Lauer U, Hausdorf G, Jungblut PR, Johnson J, Knolle PA, Zeitz M, Hamann A, Klugewitz K
Histochem Cell Biol. 2008 Apr .
2007
198. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study.
Jahnke A, Hirschberger J, Fischer C, Brill T, Köstlin R, Plank C, Küchenhoff H, Krieger S, Kamenica K, Schillinger U
J Vet Med A Physiol Pathol Clin Med. 2007 Dec .
199. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L, Walzog B, Pohl U, Krotz F
J Vasc Res. 2008 .
200. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, Brew K, Nagase H, Stangl M, von Weyhern CW, Brücher BL, Brand K, Coussens LM, Edwards DR, Krüger A
Cancer Res. 2007 Sep 15.
